Empowering Patients with Health & Life
At Gencorrex, we are focused on developing next generation gene therapy treatments for brain related rare diseases. These treatments provide the required genes to the patients cells to address the underlying cause. Our therapies aim to bring meaningful change to the lives of those who have little to no treatment options.
Our Vision
At Gencorrex, we envision a world where children and families affected by rare disease have access to life saving genetic medicines
​
​
A Focused Gene Therapy Platform Backed by Scientific Discovery
Our platform is rooted in over a decade of rigorous pre-clinical study. We are determined and dedicated to bring transformative gene therapies to patients with a focus on families of rare diseases. This focused platform ensures that we can maximize our impact in translating these therapeutics to the clinic.
A Patient-Centric Approach Rooted in Rare Disease Advocacy
Our platform has been supported by rare disease advocacy groups since the inception of our gene therapies. We pride ourselves in forming strong relationships with patient advocacy networks, promoting transparency and patient engagement throughout the entire therapeutic development process.
A Commitment to Improving Patient Access
Gencorrex was founded on the principal that every rare disease patient deserves the benefit of our gene therapies. We are committed to running global clinical programs and are looking to establish global clinical trial sites to reach the wider patient population. Do you work with a primary care institution that might be interested?